Generation of murine dendritic cells in vitro using Flt3-L and their characteristics

Abstract

Introduction. Currently, cell vaccines based on myeloid dendritic cells (mDCs) are being actively developed to modulate an adaptive immune response in order to correct certain human diseases. However, there is still little data on the effectiveness of the use of plasmacytoid dendritic cells (pDCs) for the same purposes.

Aim of the study. Development of the protocol for in vitrogeneration of mice pDCs using recombinant Flt3-L and description of the phenotypic and functional properties of the obtained dendritic cells (DCs) to address the possibility of their use in the development of cell vaccines.

Material and methods. DCs were generated from mouse bone marrow cells using Flt3-L. Frequency and phenotype of the DCs were assessed by flow cytometry. DC’s morphology was assessed using fluorescent microscopy. Treg frequency and CD4+-lymphocytes proliferation induced by DCs were assessed in mixed lymphocyte culture. The expression of CCR9 on DCs was assessed using flow cytometry.

Results. It was shown that the use of Flt3-L provides in vitrogeneration of bone marrow-derived cultures with a relatively high content of B220+CD11c+-pDCs and Sirpα+CD11c+-mDCs. The B220+CD11c+-pDCs and the Sirpα+CD11c+-mDCs obtained differed in morphology and degree of maturity. In a mixed lymphocytes culture, the dendritic cells were able to generate an increased amount of Treg and cause a reduced proliferation of CD4+-lymphocytes, thus manifesting an immature phenotype. Further maturation of the DCs via CpG DNA stimulation led to an increased immunogenicity, according the Treg reduction and enhanced CD4+-lymphocytes proliferation in mixed lymphocytes culture. We found that a relatively small number of B220+CD11c+-pDCs and Sirpα+CD11c+-mDCs carried the CCR9 chemotaxis receptor on their surface, however, the number of B220+CD11c+-pDCs and the Sirpα+CD11c+-mDCs carrying intracellular CCR9 tended to 100 %. Thus, the use of Flt3-L provides the opportunity ofin vitro generation of B220+CD11c+ pDCs and Sirpα+CD11c+-mDCs that can be useful in the field of cell vaccine development to direct an adaptive immune response decreasing undesirable immune reactions or increasing desirable.

Keywords:Flt3-L; plasmacytoid dendritic cells; myeloid dendritic cells; CCR9

For citation: Tereshchenko V.P., Bulygin A.S., Zavodskii R.Y., Kulikova E.V., Sennikov S.V. Generation of murine dendritic cells in vitro using Flt3-L and their characteristics. Immunologiya. 2019; 41(3): 215-26. DOI: 10.33029/0206-4952-2020-41-3-215-226 (in Russian)

Funding. The research was supported by the grant of the Russian Science Foundation (project no.16-15-00086).

Conflict of interests. The authors declare no conflict of interests.

References

1. Kuznetsova M., Lopatnikova J., Shevchenko J., Silkov A., Maksyutov A., Sennikov S. cytotoxic activity and memory t cell subset distribution of in vitro-stimulated CD8+ T cells specific for HER2/neu epitopes. Front. Immunol. 2019; 10: 1017. DOI: 10.3389/fimmu.2019.01017.

2. Kulikova E., Kurilin V., Shevchenko J., Obleukhova I., Khrapov E., Boyarskikh U., et al. Dendritic cells transfected with a DNA construct encoding tumour-associated antigen epitopes induce a cytotoxic immune response against autologous tumour cells in a culture of mononuclear cells from colorectal cancer patients. Scand. J. Immunol. 2015; 82 (2): 110–7. DOI: 10.1111/sji.12311.

3. Mansilla M., Sellès-Moreno C., Fàbregas-Puig S., Amoedo J., Navarro-Barriuso J., Teniente-Serra A., et al. Beneficial effect of tolerogenic dendritic cells pulsed with MOG autoantigen in experimental autoimmune encephalomyelitis. CNS Neurosci. Ther. 2015; 21 (3): 222–30. DOI: 10.1111/cns.12342.

4. Ning B., Wei J., Zhang A., Gong W., Fu J., Jia T., et al. Antigen-specific tolerogenic dendritic cells ameliorate the severity of murine collagen-induced arthritis. PLoS One. 2015; 10 (6): e0131152. DOI: 10.1371/journal.pone.0131152.

5. Sennikov S., Obleukhova I. Methods of induction of tolerant dendritic cells in animals and humans. Immunologiya. 2016; 37 (5): 291–6. DOI: 10.18821/0206-4952-2016-37-5-291-296. (in Russian)

6. Lutz M., Suri R., Niimi M., Ogilvie A., Kukutsch N., Rößner S., et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survivalin vivo. Eur. J. Immunol. 2000; 30 (7): 1813–22. DOI: 10.1002/1521-4141(200007)30:7<1813::aid-immu1813>3.0.co;2-8.

7. Fujita S., Sato Y., Sato K., Eizumi K., Fukaya T., Kubo M., et al. Regulatory dendritic cells protect against cutaneous chronic graft-versus-host disease mediated through CD4+CD25+Foxp3+ regulatory T cells. Blood. 2007; 110 (10): 3793–803. DOI: 10.1182/blood-2007-04-086470.

8. Hadeiba H., Lahl K., Edalati A., Oderup C., Habtezion A., Pachynski R., et al. Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance. Immunity. 2012; 36 (3): 438–50. DOI: 10.1016/j.immuni.2012.01.017.

9. Hadeiba H., Sato T., Habtezion A., Oderup C., Pan J., Butcher E. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 2008; 9 (11): 1253–60. DOI: 10.1038/ni.1658.

10. Mach N., Gillessen S., Wilson S., Sheehan C., Mihm M., Dranoff G. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res. 2000; 60: 3239–46.

11. Wendland M., Czeloth N., Mach N., Malissen B., Kremmer E., Pabst O., et al. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc. Natl Acad. Sci. USA. 2007; 104 (15): 6347–52. DOI: 10.1073/pnas.0609180104.

12. Zeng R., Oderup C., Yuan R., Lee M., Habtezion A., Hadeiba H., et al. Retinoic acid regulates the development of a gut-homing precursor for intestinal dendritic cells. Mucosal Immunol. 2013; 6 (4): 847–56. DOI: 10.1038/mi.2012.123.

13. Chen Y., Chang S., Chen T., Lee C. Efficient generation of plasmacytoid dendritic cell from common lymphoid progenitors by Flt3 ligand. PLoS One. 2015; 10 (8): e0135217. DOI: 10.1371/journal.pone.0135217.

14. Liu H., Ramachandran I., Gabrilovich D.I. Regulation of plasmacytoid dendritic cell development in mice by aryl hydrocarbon receptor. Immunol. Cell Biol. 2014; 92 (2): 200–3. DOI: 10.1038/icb.2013.65.

15. Brawand P., Fitzpatrick D. R., Greenfield B., Brasel K., Maliszewski C., De Smedt T. Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J. Immunol. 2002; 169 (12): 6711–9.

16. Angelov G. S., Tomkowiak M., Marcais A., Leverrier Y., Marvel J. Flt3 ligand-generated murine plasmacytoid and conventional dendritic cells differ in their capacity to prime naive CD8 T cells and to generate memory cells in vivo. J. Immunol. 2005; 175 (1): 189–95.

17. Feng T., Cong Y., Qin H., Benveniste E., Elson C. Generation of mucosal dendritic cells from bone marrow reveals a critical role of retinoic acid. J. Immunol. 2010; 185 (10): 5915–25. DOI: 10.4049/jimmunol.1001233.

18. Karrich J., Jachimowski L., Uittenbogaart C., Blom B. The plasmacytoid dendritic cell as the Swiss army knife of the immune system: molecular regulation of its multifaceted functions. J. Immunol. 2014; 193 (12): 5772–8. DOI: 10.4049/jimmunol.1401541.

19. Funderburg N., Lederman M., Feng Z., Drage M., Jadlowsky J., Harding C., et al. Human-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc. Natl Acad. Sci. USA. 2007; 104 (47): 18 631–5.

20. Bhattacharya P., Gopisetty A., Ganesh B., Sheng J., Prabhakar B. GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms. J. Leukoc. Biol. 2011; 89: 235–49.

21. Muller G., Hopken U., Stein H., Lipp M. Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors. J. Leukoc. Biol. 2002; 72 (1): 1–8.

22. Syrovatkina V., Alegre K., Dey R., Huang X. Regulation, signaling, and physiological functions of G-proteins. J. Mol. Biol. 2016; 428 (19): 3850–68. DOI: 10.1016/j.jmb.2016.08.002

23. Lee H., Kim H., Lee E., Jang M., Kim S., Park J., et al. Characterization of CCR9 expression and thymus-expressed chemokine responsiveness of the murine thymus, spleen and mesenteric lymph node. Immunobiology. 2012; 217 (4): 402–11. DOI: 10.1016/j.imbio.2011.10.014.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)


JOURNALS of «GEOTAR-Media»